Exelixis(EXEL) - 2025 Q4 - Earnings Call Transcript
Exelixis (NasdaqGS:EXEL) Q4 2025 Earnings call February 10, 2026 05:00 PM ET Company ParticipantsAakash Tewari - Global Head of Biopharmaceutical ResearchAndrew Peters - SVP of Strategy and Investor RelationsChris Senner - CFODana Aftab - EVP of Research and DevelopmentMike Morrissey - President and CEOP.J. Haley - EVP of CommercialSean Laaman - Executive DirectorConference Call ParticipantsAndy Hsieh - Biotech Equity Research AnalystAshwani Verma - Equity Research AnalystAsthika Goonewardene - Managing Dir ...